Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Convalescent Plasma for Covid-19 - Making Sense of the Inconsistencies.

Journal article

Estcourt L. and Callum J., (2022), N Engl J Med, 386, 1753 - 1754

Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.

Journal article

REMAP-CAP Writing Committee for the REMAP-CAP Investigators None. et al, (2022), JAMA

Passive immune therapies: another tool against COVID-19.

Journal article

Estcourt LJ., (2021), Hematology Am Soc Hematol Educ Program, 2021, 628 - 641

Hyperimmune immunoglobulin for people with COVID-19

Journal article

Kimber C. et al, (2021), Cochrane Database of Systematic Reviews, 2021

Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.

Journal article

Writing Committee for the REMAP-CAP Investigators None. et al, (2021), JAMA

Living systematic reviews in a context of rapidly emerging diseases: challenges and lessons learned

Conference paper

Iannizzi C. et al, (2021), EUROPEAN JOURNAL OF PUBLIC HEALTH, 31, 182 - 182

SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.

Journal article

Kreuzberger N. et al, (2021), Cochrane Database Syst Rev, 9

Methodological challenges for living systematic reviews conducted during the COVID-19 pandemic: a concept paper

Journal article

Iannizzi C. et al, (2021), Journal of Clinical Epidemiology

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.

Journal article

ATTACC Investigators None. et al, (2021), N Engl J Med, 385, 790 - 802

Load More